2 Transplant recipients

2 Transplant recipients

2.1 For patients who have had a kidney transplant:

2.2 For patients who are stable on their immunosuppressant regimen, assess whether it is safe to do less frequent blood tests for routine monitoring. Discuss any planned changes with the patient and their families and carers (as appropriate).

2.3 Prescribe usual quantities of medicines to meet the patient's clinical needs. Prescribing larger quantities of medicines may put the supply chain at risk.

2.4 If patients develop respiratory symptoms or a fever, consider other possible infective and non-infective causes as well as COVID‑19. Be aware that patients having immunosuppressant treatments may have atypical presentations of COVID‑19. For example, patients taking prednisolone may not develop a fever.